Levine Cancer Institute Concord is a clinical research site located in Concord, North Carolina, United States 28205.
Crixeo Clinical Trials Trust Score: 14/100 (FAILING). This profile has not yet been claimed by the site owner.
Levine Cancer Institute Concord has participated in 5 clinical trials with 3 currently active.
Therapeutic areas: Relapsed/Refractory Follicular Lymphoma, Follicular Lymphoma, Refractory Follicular Lymphoma.
Sponsors: Epizyme, Inc., Wake Forest University Health Sciences, Seagen, a wholly owned subsidiary of Pfizer.
Is this your site? Claim your profile and control the information sponsors and patients see.
Browse all research sites in North Carolina · View every site in Concord
Trust Score: 14/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Levine Cancer Institute Concord has a Crixeo Trust Score of 14/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Levine Cancer Institute Concord has 5 clinical trials on record, with 3 currently active. Their work covers Relapsed/Refractory Follicular Lymphoma, Follicular Lymphoma, Refractory Follicular Lymphoma.
Levine Cancer Institute Concord has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.